DESENVOLVIMENTO DE APLICATIVO MÓVEL PARA ACOMPANHAMENTO DE COMPLICAÇÕES EM PACIENTES HIPERTENSOS E DIABÉTICOS ACOMETIDOS POR COVID-19 NA ATENÇÃO PRIMÁRIA À SAÚDE

Abstract

Introduction: Systemic Arterial Hypertension and Diabetes Mellitus constitute noncommunicable chronic diseases with high prevalence and significant impact on morbidity and mortality, especially when associated with COVID-19 infection, whose interaction potentiates the risk of cardiovascular, renal, and metabolic complications. Within the Primary Health Care context, the pandemic imposed important challenges to the longitudinal follow-up of these patients, highlighting difficulties in care continuity and systematization of post-infection clinical monitoring. From this scenario, the delimitation of the research object was supported by the application of the GUT Matrix (Gravity, Urgency, and Tendency), a tool that enabled systematic analysis of problems faced within Primary Health Care. Therefore, the study sought to answer "What functionalities, content, and technical characteristics should comprise a mobile application aimed at monitoring complications in hypertensive and diabetic patients affected by COVID-19 within Primary Health Care?" Objective(s): To develop a mobile application for monitoring complications in hypertensive and diabetic patients who were affected by COVID-19. Methodological Procedures: This is a technological production study with a quantitative approach, supported by software engineering and grounded in the systems development life cycle. To achieve the proposed objectives, this research stage followed the following phases: Stage 1 – Scoping Review, entitled “Mapping mobile applications for monitoring chronic conditions in patients previously affected by COVID-19 in primary health care: a scoping review”, which was submitted and registered on the OSF platform using the OSF pre-registration model, under the identifier DOI: 10.17605/OSF.IO/29C5Q; Stage 2 – Requirements Gathering for mobile technology structuring; Stage 3 – Development of the Technological Production Life Cycle. Results: The synthesis of the ten studies included in the Scoping Review revealed that mobile technologies designed to monitor people with hypertension and diabetes mellitus predominantly present fragmented functional organization, a focus on punctual records of clinical parameters and self-management strategies, limitations in the incorporation of longitudinal care, and low integration between clinical, laboratory, and follow-up data. Based on these findings, the clinical, functional, and operational requirements considered essential for the construction of the technology were systematized, encompassing blood pressure and blood glucose monitoring, structured recording of post-COVID-19 signs and symptoms, evolutionary monitoring of tests and medications, as well as resources for risk stratification, longitudinal visualization, and organization of clinical follow-up. Thus, the Cronicov mobile application was developed, structured according to an architectural model guided by agile methodology in the context of Primary Health Care. Conclusions: The mobile application development transformed a concrete Primary Health Care need into a technological solution for monitoring people with hypertension and diabetes affected by COVID-19. Despite challenges in organizing information and care flows, it was possible to build a structured tool with potential for use in team routines. The study objective was achieved, recognizing, however, the need for validation, usability evaluation, and impact measurement. Thus, the work contributes both as a technological product and by presenting a methodological pathway applicable to the integration of research, technology, and health practice within the Unified Health System.